Jamie M. Brickell is a partner in Pryor Cashman's Litigation Group. During his 27-year career, Jamie has handled a variety of complex commercial cases. His experience includes matters relating to antitrust, securities fraud and RICO, intellectual property, corporate, partnership and joint venture litigations, as well as disputes concerning non-compete agreements and the protection of proprietary information and materials. Jamie has successfully handled numerous bench trials, jury trials and arbitrations. He has also conducted and concluded complex and multi-party mediations and settlement negotiations.

Jamie has represented plaintiffs in commercial litigations in a number of areas, including breach of written and oral contracts, earnout disputes, fraudulent inducement claims and claims concerning the rights of parties in partnerships and closely held corporations.

Of particular note, Jamie obtained two significant decisions against public companies within the past seven years, both of which involved claims that an acquiring company failed to act in good faith to the detriment of the seller, thereby depriving it of substantial earn out payments.

In 2003, Jamie represented the plaintiffs in a breach of contract and fraud dispute involving the sale of a medical program for the treatment of prostate cancer. After a five-week federal court trial, Jamie's clients received a $58 million unanimous jury verdict. The matter settled after trial and the terms of the settlement are confidential, but the verdict was the fourth largest in New York State and the 30th largest in the United States for 2003.

In December 2007, Jamie obtained a $12.7 million arbitration award on behalf of the former shareholders of CryoGen, Inc. (CryoGen) against American Medical Systems Inc (AMS), including more than $1 million in legal fees and costs. The AAA panel concluded that AMS failed to use “commercially reasonable” effort in its development and exploitation of CryoGen’s “Her Option” product.  The panel also summarily dismissed AMS’ fraud counterclaims immediately after the conclusion of the two week arbitration conducted in Chicago in July 2007. Pryor Cashman's clients in the matter included JHK Investments, Kleiner Perkins and Invesco.